{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-002304","form_type":"8-K","ticker":"PSNL","cik":"0001527753","company_name":"Personalis, Inc.","filed_at":"2024-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.503976+00:00","generated_at":"2026-06-07T03:04:41.675204+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Personalis reports Q4 revenue of $19.7M (+18% YoY); cash runway extended to Q1 2026","bullets":["Preliminary Q4 revenue $19.7M, up 18% YoY from $16.7M; full-year revenue $73.5M, up 13%.","Natera revenue in Q4 was $7.1M (vs $8.2M prior year); pharma/enterprise/other revenue $18.7M.","Cash and short-term investments $114.0M; cash usage reduced to ~$54M in 2023 from $119M.","Annual cost-cutting reduced expenses by ~$35M; cash runway extended to Q1 2026.","CEO cites NeXT Personal Dx launch, Tempus partnership, and progress on clinical evidence."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-002304","json":"https://secwatch.observer/filing/0000950170-24-002304.json","markdown":"https://secwatch.observer/filing/0000950170-24-002304.md","text":"https://secwatch.observer/filing/0000950170-24-002304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527753/000095017024002304/0000950170-24-002304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527753/000095017024002304/psnl-20240105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T03:04:41.675204+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"75744d21a998b0c08edab12ae25deef84a2a6723","claim":"Personalis, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $19.7 million.","evidence_excerpt":"Preliminary total company revenue is estimated to be $19.7 million in the fourth quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527753/000095017024002304/0000950170-24-002304-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$19.7 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"ec205fccafc6a0d43fc2a16c1e716958bc061160","claim":"Personalis, Inc. reported the full year ended December 31, 2023 results: revenue $73.5 million.","evidence_excerpt":"Preliminary total company revenue is estimated to be $73.5 million in the full year of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527753/000095017024002304/0000950170-24-002304-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"$73.5 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}